Spyre Therapeutics
CompanyWaltham, United States· Biotech
US clinical-stage biotech for inflammatory bowel disease.
Minutes holds 1 development and 1 deal naming Spyre Therapeutics, recorded from October 2026.
Intelligence
Deals in Minutes
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| Spyre TherapeuticsBiotech | FundingPublic offering | $350M | Not recorded | 5 Oct | Closed |